S1PR1/S1PR3-YAP signaling and S1P-ALOX15 signaling contribute to an aggressive behavior in obesity-lymphoma

• Published in: Journal of experimental & clinical cancer research 2023-01, Vol.42 (1), p.3-3, Article 3
• Main Authors: Wang, Xingtong, Guo, Wei, Shi, Xiaoju, Chen, Yujia, Yu, Youxi, Du, Beibei, Tan, Min, Tong, Li, Wang, Anna, Yin, Xianying, Guo, Jing, Martin, Robert C, Bai, Ou, Li, Yan
• Format: Article
• Language: English
• Subjects: Analysis; Animals; Arachidonate 12-Lipoxygenase - metabolism; Arachidonate 15-Lipoxygenase; Body weight; Disease Models, Animal; Fatty acids; Free fatty acid; Gene expression; Genes; Humans; Lymphoma; Macrophages; Medical research; Medicine, Experimental; Metabolites; Mice; Neoplasms; Non-Hodgkin's lymphomas; Obesity; Obesity - complications; Obesity - genetics; Phosphates; Phosphotransferases (Alcohol Group Acceptor) - metabolism; Prognosis; Resveratrol; S1P/SPHK signaling; Signal Transduction; Sphingosine; Sphingosine-1-Phosphate Receptors - metabolism; Tumor Microenvironment
• ISSN: 1756-9966; 0392-9078; 1756-9966
• DOI: 10.1186/s13046-022-02589-7

Excess body weight has been found to associate with an increased risk of lymphomas and some metabolic pathways are currently recognized in lymphomagenesis. Bioactive lipid metabolites such as sphingosine-1-phosphate (S1P) have been proposed to play an important role linking obesity and lymphomas. However, the underlying mechanism(s) of S1P signaling in obesity-lymphomagenesis have not been well addressed. The gene expression of sphingosine kinase (SPHK), lymphoma prognosis, and S1P production were analyzed using Gene Expression Omnibus (GEO) and human lymphoma tissue array. Obesity-lymphoma mouse models and lymphoma cell lines were used to investigate the S1P/SPHK-YAP axis contributing to obesity-lymphomagenesis. By using the mouse models and a monocyte cell line, S1P-mediated polarization of macrophages in the tumor microenvironment were investigated. In human study, up-regulated S1P/SPHK1 was found in human lymphomas, while obesity negatively impacted progression-free survival and overall survival in lymphoma patients. In animal study, obesity-lymphoma mice showed an aggressive tumor growth pattern. Both in vivo and in vitro data suggested the existence of S1P-YAP axis in lymphoma cells, while the S1P-ALOX15 signaling mediated macrophage polarization towards TAMs exacerbated the lymphomagenesis. In addition, treatment with resveratrol in obesity-lymphoma mice showed profound effects of anti-lymphomagenesis, via down-regulating S1P-YAP axis and modulating polarization of macrophages. S1P/S1PR initiated the feedback loops, whereby S1P-S1PR1/S1PR3-YAP signaling mediated lymphomagenesis contributing to tumor aggressive growth, while S1P-ALOX15 signaling mediated TAMs contributing to immunosuppressive microenvironment in obesity-lymphoma. S1P-targeted therapy could be potentially effective and immune-enhancive against obesity-lymphomagenesis.